![]() |
市場調查報告書
商品編碼
1729538
日本神經學設備市場報告(按設備類型(腦脊髓液管理設備、介入性神經病學設備、神經外科設備、神經刺激設備等)和地區)2025 年至 2033 年Japan Neurology Devices Market Report by Type of Device (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices, Neurostimulation Devices, and Others), and Region 2025-2033 |
2024 年,日本神經病學設備市場規模達 8.52 億美元。展望未來, IMARC Group預計到 2033 年市場規模將達到 13.14 億美元,2025-2033 年期間的成長率 (CAGR) 為 4.9%。神經系統疾病盛行率的上升以及技術的不斷進步是推動市場成長的主要動力。
神經病學是醫學科學的一個分支,致力於解決神經系統內的疾病和異常。神經病學領域通常使用各種類型的儀器。例如,骶神經刺激裝置是透過向位於背部下部的指定骶神經傳輸電訊號來運作。相反,腦脊髓液管理裝置負責調節腦脊髓液的流動並排出腦中多餘的液體。類似地,介入設備利用放射技術和導管來診斷影響中樞神經系統的疾病,而深部腦刺激設備則透過植入向大腦特定目標區域發射電脈衝的設備來協助醫療程序。這些設備在解決複雜疾病方面發揮關鍵作用。因此,它們被廣泛應用於治療多種神經系統疾病,包括但不限於強迫症、帕金森氏症、肌張力失調、慢性疼痛、特發性震顫和重度憂鬱症。
日本神經病學市場主要受到醫療保健行業的大幅成長的推動。此外,神經系統疾病盛行率的不斷上升極大地推動了對這些產品的需求,從而對區域市場產生了積極影響。老年人口的增加以及老年人中風等神經血管疾病發生率的增加也加速了神經病學設備的普及,從而促進了市場的成長。此外,神經病學設備的技術不斷進步以及對微創(MI)手術的廣泛需求也是促進日本成長的重要因素。推動市場擴張的其他因素包括醫療保健支出的增加、全球醫療器材製造商的大量投資以及神經治療領域的廣泛研發 (R&D) 活動。此外,預計醫療產業的眾多技術進步將在預測期內推動市場成長。
市場研究報告也對市場競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外,也提供了所有主要公司的詳細資料。
Japan neurology devices market size reached USD 852.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,314.0 Million by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The rising prevalence of neurological disorders, along with the continual technological advancements, is primarily driving the market growth.
Neurology is a branch of medical science dedicated to addressing conditions and irregularities within the nervous system. Various categories of instruments are commonly employed in the field of neurology. For instance, sacral nerve stimulation apparatus operates by transmitting electrical signals to the designated sacral nerves situated in the lower part of the back. Conversely, devices for cerebrospinal fluid management are responsible for regulating the flow of cerebrospinal fluid and draining any excess fluid from the brain. In a similar vein, interventional equipment utilizes radiological techniques and catheters to diagnose medical conditions affecting the central nervous system, while deep brain stimulation devices assist in medical procedures by implanting a device that emits electrical impulses to specific target regions in the brain. These devices play a pivotal role in addressing intricate disorders. Consequently, they are extensively employed in the treatment of a multitude of neurological ailments, including but not limited to obsessive-compulsive disorder, Parkinson's disease, dystonia, chronic pain, essential tremor, and major depression.
The neurology market in Japan is primarily being fueled by substantial growth within the healthcare sector. Furthermore, the increasing prevalence of neurological disorders is substantially driving the demand for these products, which is positively influencing the regional market. The rising elderly population and the growing occurrences of neurovascular conditions, such as strokes, among older individuals are also accelerating the adoption of neurology devices, thereby bolstering the market growth. Additionally, continuous technological advancements in neurology devices and the widespread demand for minimally invasive (MI) surgical procedures are also serving as significant factors that encourage growth in Japan. Other factors that are giving a boost to market expansion include the increasing healthcare expenditure, substantial investments by global medical device manufacturers, and extensive research and development (R&D) activities in the field of neurotherapy. Furthermore, numerous technological advancements in the medical industry are anticipated to fuel the market growth over the forecasted period.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.